Although DD-localized CD95 mutations foster tumor progression by rendering tumor cells resistant to the apoptotic response (33), new and accumulating evidence support that this receptor exerts more complex biological functions, and might promote oncogenesis and inflammation/auto-immunity independently of its ability to trigger cell death (3, 34–36). Here, FAS is linked to neoplasm.